Publicacións en colaboración con investigadores/as de Hospital Vall d'Hebron (23)

2024

  1. Atorvastatin Effect on Aortic Dilatation and Valvular Calcification Progression in Bicuspid Aortic Valve (BICATOR): A Randomized Clinical Trial

    Circulation, Vol. 149, Núm. 25, pp. 1938-1948

  2. Prognostic impact of shock in patients with type A acute aortic syndrome. Results of a nationwide multicenter study

    Hellenic Journal of Cardiology

2023

  1. Changes in echocardiographic parameters over time in paradoxical low-flow low-gradient aortic stenosis

    European heart journal. Cardiovascular Imaging, Vol. 24, Núm. 8, pp. 1120-1128

  2. Clinical Outcomes in Patients With Bicuspid Aortic Valves and Ascending Aorta ≥50 mm Under Surveillance

    JACC: Advances, Vol. 2, Núm. 8

  3. Invasive management of significant tricuspid regurgitation in clinical practice

    International Journal of Cardiology, Vol. 375, pp. 66-73

2022

  1. Spanish Registry of Acute Aortic Syndrome (RESA). Changes in therapeutic management and lower mortality in acute aortic syndrome

    Revista Espanola de Cardiologia, Vol. 75, Núm. 10, pp. 817-825

2019

  1. Familial clustering of bicuspid aortic valve and its relationship with aortic dilation in first-degree relatives

    Heart, Vol. 105, Núm. 8, pp. 603-608

  2. The ESC-EORP EURO-ENDO (European Infective Endocarditis) registry

    European Heart Journal - Quality of Care and Clinical Outcomes, Vol. 5, Núm. 3, pp. 202-207

2018

  1. Anatomical and clinical predictors of valve dysfunction and aortic dilation in bicuspid aortic valve disease

    Heart, Vol. 104, Núm. 7, pp. 566-573

  2. Diagnosis, management and mortality in acute aortic syndrome: results of the Spanish Registry of Acute Aortic Syndrome (RESA-II)

    European heart journal. Acute cardiovascular care, Vol. 7, Núm. 7, pp. 602-608

2000

  1. Strategy for optimal aortic regurgitation quantification by Doppler echocardiography: Agreement among different methods

    American Heart Journal, Vol. 139, Núm. 5, pp. 773-781

1999

  1. Attenuated severity of new acute ischemic events in patients with previous coronary heart disease receiving long-acting nitrates

    Clinical Cardiology, Vol. 22, Núm. 4, pp. 303-308

  2. Validation of the Agency for Health Care Policy and Research (AHCPR) classification for managing unstable angina

    Journal of Clinical Epidemiology, Vol. 52, Núm. 10, pp. 959-965

1998

  1. Is prophylactic treatment after myocardial infarction evidence-based?

    Family Practice, Vol. 15, Núm. 5, pp. 457-461

  2. Mitral regurgitation after acute myocardial infarction

    Cardiology Review, Vol. 15, Núm. 9, pp. 37-40

  3. Patients with acute coronary syndrome: Therapeutic management and one-year prognosis in a tertiary hospital

    Revista Espanola de Cardiologia, Vol. 51, Núm. 12, pp. 954-964

  4. Relevance of delayed hospital admission on development of cardiac rupture during acute myocardial infarction: Study in 225 patients with free wall, septal or papillary muscle rupture

    Journal of the American College of Cardiology, Vol. 32, Núm. 1, pp. 135-139

1997

  1. Comparison of patients with and without papillary muscle rupture during acute myocardial infarction

    American Journal of Cardiology, Vol. 80, Núm. 5, pp. 625-627

  2. Severe mitral regurgitation complicating acute myocardial infarction. Clinical and angiographic differences between patients with and without papillary muscle rupture

    European Heart Journal, Vol. 18, Núm. 10, pp. 1606-1610

1996

  1. Deben recibir tratamiento continuado con aspirina los individuos sin evidencia de enfermedad coronaria y con factores de riesgo? Argumentos a favor

    Revista Espanola de Cardiologia, Vol. 49, Núm. 11, pp. 793-800